Slideshow
Author(s):
New research may help doctors determine when (and when not) to test for antiglutamate decarboxylase antibodies in patients with neurological disorders and psychiatric symptoms.
NeurologyLive® Friday 5 — April 25, 2025
Episode 139: Sleep and Seizures: Emerging Insights From AAN 2025
NeurologyLive® Brain Games: April 20, 2025
Episode 136: Raising Epilepsy Awareness for Purple Day
Revolutionizing Neurology Care: Previewing Cleveland Clinic’s New Neurological Institute
Phase 3 Study to Test 1st Generation Antihistamine EPX-100 in Lennox-Gastaut Syndrome